Use of mesenchymal stem cells in therapy of tuberculosis
Open Access
- 14 May 2022
- journal article
- review article
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (4) , 62-66
Abstract
This review presents data from 29 publications on the use of mesenchymal stem cells in the therapy of tuberculosis of various localizations. It also describes some mechanisms of interaction between mesenchymal stem cells and M. tuberculosis.Keywords
This publication has 26 references indexed in Scilit:
- CD271 + Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosisScience Translational Medicine, 2013
- Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Mycobacterium tuberculosisevades host immunity by recruiting mesenchymal stem cellsProceedings of the National Academy of Sciences, 2010
- Mesenchymal stem cells for acute lung injury: Preclinical evidenceCritical Care Medicine, 2010
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis BacilliChest, 2009
- Prevention of LPS-Induced Acute Lung Injury in Mice by Mesenchymal Stem Cells Overexpressing Angiopoietin 1PLOS Medicine, 2007
- M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid CellsCell, 2007
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007
- Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected MacrophagesCell, 2004
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994